|
|
|
16.02.26 - 04:45
|
Research: Nomura Lifts CSPC PHARMA (01093.HK) TP to $12.04, Keeps Buy Rating (AAStocks)
|
|
|
Nomura issued a research report expecting that CSPC PHARMA (01093.HK)'s 4Q25 revenue will grow by 20% YoY to RMB7.6 billion, slightly higher than the market consensus of RMB7.4 billion. The broker also anticipated that the sales of finished drugs will ebb by 1% YoY to RMB5 billion, while collaboration revenue will be RMB1.1 ......
|
|
|
10.02.26 - 09:15
|
Full-day Takeaway: HSI Closes at 27,183, Up 155 pts; HSTI Closes at 5,451, Up 33 pts; CSPC PHARMA Up over 5%; ZTO EXPRESS-W, WH GROUP, BOC HONG KONG, WHARF REIC, HANG LUNG PPT Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 155 pts or 0.6% to 27,183. HSTI rose 33 pts or 0.6% to 5,451. HSCEI gained 74 pts or 0.8% to 9,242. Market turnover reached $234.04 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $88.8, down 2.5%BABA (09988.HK) closed at $160.5, up 1.6%TENCENT (00700.HK) closed at $551, down 1.6%XIAOMI (01810.HK) clo......
|
|
|
03.02.26 - 09:15
|
Full-day Takeaway: HSI Closes at 26,834, Up 59 pts; HSTI Closes at 5,467, Down 59 pts; CSPC PHARMA Up over 8%; NEW ORIENTAL, HSBC HOLDINGS, MTR CORPORATION, POWER ASSETS, CIMC Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 59 pts or 0.2% to 26,834. HSTI dropped 59 pts or 1.1% to 5,467. HSCEI fell 27 pts or 0.3% to 9,053. Market turnover reached $335.15 billion.Active Heavyweights:TENCENT (00700.HK) closed at $581, down 2.9%MEITUAN (03690.HK) closed at $93.2, down 1.7%BABA (09988.HK) closed at $161, down 1.4%XIAOMI (01810.HK) clo......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.01.26 - 11:30
|
HKD934.6M Southbound Trading Net Inflow to CSPC PHARMA (AAStocks)
|
|
|
There was HKD934.6 million, HKD914 million and HKD329.8 million Southbound Trading net inflow to CSPC PHARMA (01093.HK), XIAOMI-W (01810.HK) and BABA-W (09988.HK).There was HKD635.5 million, HKD525.5 million and HKD213.4 million Southbound Trading net outflow from ZIJIN MINING (02899.HK), CNOOC (00883.HK) and TENCENT (00700.HK).......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.01.26 - 08:00
|
AstraZeneca agrees obesity and T2D deal with CSPC (Cision)
|
|
|
30 January 2026
AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals
Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovative monthly dosing technology
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes. Under this agreement, the...
|
|
|
|
|
|
|
|